XML 31 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 30, 2023
Investments Debt And Equity Securities [Abstract]  
Cash Equivalents and Marketable Securities

4. Cash Equivalents and Marketable Securities

The following tables summarize the estimated fair value of the Company’s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):

 

 

June 30, 2023

 

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Estimated
Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

18,861

 

 

$

 

 

$

 

 

$

18,861

 

Total cash equivalents

 

$

18,861

 

 

$

 

 

$

 

 

$

18,861

 

 

 

 

 

 

 

 

December 31, 2022

 

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Estimated
Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

15,250

 

 

$

 

 

$

 

 

$

15,250

 

Commercial paper

 

 

7,021

 

 

 

1

 

 

 

(2

)

 

 

7,020

 

U.S. government securities

 

 

3,736

 

 

 

 

 

 

(1

)

 

 

3,735

 

Total cash equivalents

 

$

26,007

 

 

$

1

 

 

$

(3

)

 

$

26,005

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

16,644

 

 

$

2

 

 

$

(25

)

 

$

16,621

 

Corporate bonds

 

 

3,738

 

 

 

 

 

 

(6

)

 

 

3,732

 

U.S. government securities

 

 

495

 

 

 

 

 

 

 

 

 

495

 

Total marketable securities

 

$

20,877

 

 

$

2

 

 

$

(31

)

 

$

20,848

 

 

As of June 30, 2023, the Company did not hold any available-for-sale securities. The following table summarizes the available-for-sale securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of December 31, 2022, aggregated by major security type and length of time in a continuous unrealized loss position:

 

 

 

December 31, 2022

 

 

 

Less Than 12 Months

 

 

12 Months or Longer

 

 

Total

 

 

 

Fair Value

 

 

Unrealized
Losses

 

 

Fair Value

 

 

Unrealized
Losses

 

 

Fair Value

 

 

Unrealized
Losses

 

Commercial paper

 

$

17,699

 

 

$

(27

)

 

$

 

 

$

 

 

$

17,699

 

 

$

(27

)

U.S. government securities

 

 

3,735

 

 

 

(1

)

 

 

 

 

 

 

 

 

3,735

 

 

$

(1

)

Corporate bonds

 

 

3,732

 

 

 

(6

)

 

 

 

 

 

 

 

 

3,732

 

 

 

(6

)

Total marketable securities

 

$

25,166

 

 

$

(34

)

 

$

 

 

$

 

 

$

25,166

 

 

$

(34

)

 

The Company evaluated its securities for credit losses and considered the decline in market value to be primarily attributable to current economic and market conditions and not to a credit loss or other factors. Additionally, the Company does not intend to sell the securities in an unrealized loss position and does not expect it will be required to sell the securities before recovery of the unamortized cost basis. As of June 30, 2023 and December 31, 2022, an allowance for credit losses had not been recognized. Given the Company's intent and ability to hold such securities until recovery, and the lack of significant change in credit risk of these investments, the Company does not consider these marketable securities to be impaired as of June 30, 2023 and December 31, 2022.

The financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash deposits. Accounts at each of our three U.S. banking institutions are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per depositor. At June 30, 2023 and December 31, 2022, the Company had $215.6 million and $23.5 million, respectively, of U.S. cash deposits in excess of the FDIC insured limit. Uninsured foreign cash deposits were immaterial for both periods.

There were no realized gains or losses on marketable securities for the three and six months ended June 30, 2023 and 2022. Interest on marketable securities is included in interest income. Accrued interest receivable on available-for-sale

debt securities was $0.1 million at each of June 30, 2023 and December 31, 2022, and is excluded from the estimate of credit losses.

The following table summarizes the contractual maturities of the Company’s marketable securities at estimated fair value (in thousands):

 

 

 

June 30,

 

 

December 31,

 

 

 

2023

 

 

2022

 

Due in one year or less

 

$

 

 

$

20,848

 

Due thereafter

 

 

 

 

 

 

Total marketable securities

 

$

 

 

$

20,848

 

 

The Company may sell investments at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies marketable securities, including securities with maturities beyond twelve months as current assets.